This December 2019 Health Canada warning about Gilenya birth defects, ” “GILENYA (fingolimod) – Risk of Congenital Malformations”, starts with these two points: When used during pregnancy, GILENYA (fingolimod) has been associated with an increased risk of major congenital malformations, including congenital heart disease such as atrial septal … [Read more...]
Could Beta-Blocker Use in Pregnant Women Cause Fetal Heart Defects?
On April 3, 2017, updated results from the National Birth Defects Prevention Study (NBDPS) were released and published in the article "Maternal Antihypertensive Medication Use and Congenital Heart Defects" (Abstract only). This study found that there was a statistically significant association between β-blocker use in pregnant women and fetal … [Read more...]